+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Efficacy of bacillus thuringiensis israelensis, vectobac (R) WG and DT, formulations against dengue mosquito vectors in cement potable water jars in Cambodia



Efficacy of bacillus thuringiensis israelensis, vectobac (R) WG and DT, formulations against dengue mosquito vectors in cement potable water jars in Cambodia



Southeast Asian Journal of Tropical Medicine and Public Health 38(2): 261-268



This study reports the evaluation of Bacillus thuringiensis israelensis (Bti), a biological larvicide, in cement jars holding river, well and rain water. Two Bti formulations, VectoBac WG (R) and VectoBac DT (R), were evaluated in a village in Phnom Penh. Thirty-one households with cement jars supporting the colonization of Ae.aegypti immatures were chosen. In each house 3 jars were aligned next to each another and filled with the same type of water. One of the 3 jars was treated with VectoBac WG (R) at 0.4 g per 50 liters, a second jar was treated with VectoBac DT (R) at 1 tablet per 50 liters, and a third jar was an untreated control (UTC). The jars were not covered, kept outdoors and not subjected to water exchange activity. The efficacy of VectoBac (R) to control natural Ae.aegypti infestation was measured by Ae.aegypti pupae surveillance, conducted 3 days per week for 3 months post-treatment (June - September 2004). All pupae were removed, allowed to emerge in the Cambodia National Malaria Center insectarium and the emerged adults were identified and counted. The VectoBac treatments were more effective in river water, followed by well and rain water. The VectoBac treatments significantly reduced the pupae numbers for a minimum of 3 months in the river water and 2.5 months in the well water (p < 0.05). In the rain water, the pupae densities in the VectoBac WG (R) and DT (R) treated jars were not significantly different from the untreated jars, although the treated jars yielded 2.0 to 5.2 fold less pupae, respectively, than in the untreated jars during the 3 months post-treatment. The efficacy of VectoBac WG (R) to control Ae.aegypti was similar to the efficacy of VectoBac DT (R) in the 3 water types (p > 0.05). It was also observed that VectoBac WG (R) and DT (R) were target specific, without any adverse effects on aquatic predatory insects common in well and rain water. VectoBac WG (R) and DT (R) were found to be easy-to-use formulations, with no need to repackage them prior to use in the containers. The amounts of VectoBac WG (R) and DT (R) used were 12.5 fold less by weight than temephos (Abate 1.0% SG (R)).

(PDF emailed within 1 workday: $29.90)

Accession: 015677132

Download citation: RISBibTeXText

PMID: 17539275


Related references

Efficacy of a Bacillus thuringiensis israelensis tablet formulation, vectobac DT, for control of dengue mosquito vectors in potable water containers. Southeast Asian Journal of Tropical Medicine and Public Health 36(4): 879-892, 2005

Efficacy of VectoBac WG, a bacillus thuringiensis Israelensis formulation, to control dengue mosquito vectors in Cambodia. 2007

Impact of larviciding with a Bacillus thuringiensis israelensis formulation, VectoBac WG, on dengue mosquito vectors in a dengue endemic site in Selangor State, Malaysia. Southeast Asian Journal of Tropical Medicine and Public Health 39(4): 601-609, 2008

Impact of larviciding with a Bacillus thuringiensis israelensis formulation, VectoBac WGReg, on dengue mosquito vectors in a dengue endemic site in Selangor state, Malaysia. Southeast Asian Journal Of Tropical Medicine And Public Health: 4, 601-609, 2008

Efficacy of VectoBac (Bacillus thuringiensis variety israelensis) formulations for mosquito control in Australia. Journal of Economic Entomology 96(6): 1786-1791, 2003

Efficacy of aqueous suspension and granular formulations of Bacillus thuringiensis (Vectobac) against mosquito vectors. Acta Tropica 75(2): 243-246, 2000

Indoor thermal fogging against vector mosquitoes with two Bacillus thuringiensis israelensis formulations, Vectobac ABG 6511 water-dispersible granules and Vectobac 12AS liquid. Journal of the American Mosquito Control Association 18(1): 52-56, 2002

The efficacy and longevity of VectoBac (R) 12 AS and VectoBac (R) G (both based on Bacillus thuringiensis subsp israelensis) for the control of mosquitoes in Turkey. Turkish Journal of Zoology 31(4): 317-323, 2007

Efficacy of several formulations of Bacillus thuringiensis var. israelensis against three species of mosquito larvae in fresh, brackish and polluted water. Journal of the Florida Anti Mosquito Association 55(1): 9-13, 1984

Mosquito control and bacterial flora in water enriched with organic matter and treated with Bacillus thuringiensis subsp. israelensis and Bacillus sphaericus formulations. Journal of Vector Ecology 24(2): 138-153, 2000

Bacterial Larvicide, Bacillus thuringiensis israelensis Strain AM 65-52 Water Dispersible Granule Formulation Impacts Both Dengue Vector, Aedes aegypti (L.) Population Density and Disease Transmission in Cambodia. Plos Neglected Tropical Diseases 10(9): E0004973, 2017

Efficacy of arosurf monomolecular surface film base formulations of bacillus thuringiensis var israelensis against mixed populations of mosquito larvae and pupae bioassay and preliminary field evaluations. Mosquito News 44(4): 537-543, 1984

Effectiveness of two formulations of Bacillus thuringiensis var. israelensis on mosquito larvae. Chinese Journal of Entomology 13(2): 177-185, 1993

Evaluation of commercial formulations of Bacillus thuringiensis var. israelensis against dengue vector. Tropical Biomedicine 21(1): 77-81, 2004

Larvicidal potential of microbial agents Bacillus thuringiensis var. israelensis and Bacillus sphaericus against mosquito vectors prevalent in arid areas. 2007